Fort Washington Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.7M Buy
52,264
+39
+0.1% +$39.8K 0.32% 79
2026
Q1
$48M Buy
52,225
+2,257
+5% +$2.29M 0.27% 96
2025
Q4
$53.7M Buy
49,968
+1,053
+2% +$1.01M 0.29% 87
2025
Q3
$37.3M Buy
48,915
+14,301
+41% +$10.6M 0.2% 112
2025
Q2
$27M Buy
34,614
+32,081
+1,267% +$24.9M 0.16% 131
2025
Q1
$2.09M Buy
2,533
+307
+14% +$255K 0.01% 252
2024
Q4
$1.72M Buy
2,226
+44
+2% +$36.4K 0.01% 253
2024
Q3
$1.93M Buy
2,182
+50
+2% +$45K 0.01% 248
2024
Q2
$1.93M Buy
2,132
+3
+0.1% +$2.4K 0.01% 255
2024
Q1
$1.66M Hold
2,129
0.01% 266
2023
Q4
$1.24M Sell
2,129
-11
-0.5% -$6.42K 0.01% 269
2023
Q3
$1.15M Sell
2,140
-71
-3% -$36.6K 0.01% 265
2023
Q2
$1.04M Sell
2,211
-152
-6% -$63.7K 0.01% 274
2023
Q1
$812K Buy
2,363
+22
+0.9% +$7.42K 0.01% 281
2022
Q4
$856K Sell
2,341
-6,099
-72% -$2.16M 0.01% 282
2022
Q3
$2.73M Sell
8,440
-100
-1% -$31.7K 0.02% 238
2022
Q2
$2.77M Sell
8,540
-10
-0.1% -$3K 0.02% 232
2022
Q1
$2.45M Sell
8,550
-20
-0.2% -$5.15K 0.02% 248
2021
Q4
$2.37M Sell
8,570
-18
-0.2% -$4.56K 0.01% 256
2021
Q3
$1.98M Sell
8,588
-172
-2% -$42.5K 0.01% 264
2021
Q2
$2.01M Hold
8,760
0.02% 268
2021
Q1
$1.64M Hold
8,760
0.02% 279
2020
Q4
$1.48M Hold
8,760
0.02% 284
2020
Q3
$1.3M Sell
8,760
-19,532
-69% -$3.02M 0.01% 291
2020
Q2
$4.64M Sell
28,292
-36,285
-56% -$5.57M 0.05% 216
2020
Q1
$8.96M Buy
64,577
+2,897
+5% +$398K 0.12% 130
2019
Q4
$8.11M Buy
61,680
+13,240
+27% +$1.53M 0.09% 197
2019
Q3
$5.42M Buy
48,440
+16,281
+51% +$1.81M 0.06% 212
2019
Q2
$3.56M Sell
32,159
-300
-0.9% -$35.3K 0.04% 227
2019
Q1
$4.21M Sell
32,459
-4,460
-12% -$542K 0.05% 213
2018
Q4
$4.27M Sell
36,919
-13,567
-27% -$1.52M 0.05% 197
2018
Q3
$5.42M Sell
50,486
-418
-0.8% -$41.8K 0.05% 211
2018
Q2
$4.34M Sell
50,904
-193,305
-79% -$15.9M 0.04% 227
2018
Q1
$18.9M Sell
244,209
-8,809
-3% -$709K 0.2% 106
2017
Q4
$21.4M Buy
253,018
+192,635
+319% +$16.4M 0.21% 97
2017
Q3
$5.17M Buy
60,383
+3,350
+6% +$275K 0.08% 135
2017
Q2
$4.69M Hold
57,033
0.07% 143
2017
Q1
$4.8M Buy
57,033
+300
+0.5% +$24K 0.08% 140
2016
Q4
$4.17M Sell
56,733
-250
-0.4% -$18.6K 0.07% 141
2016
Q3
$4.57M Buy
56,983
+23,276
+69% +$1.86M 0.08% 125
2016
Q2
$2.65M Buy
33,707
+3,000
+10% +$226K 0.05% 177
2016
Q1
$2.21M Sell
30,707
-12
-0% -$908 0.04% 198
2015
Q4
$2.59M Buy
30,719
+12
+0% +$996 0.05% 186
2015
Q3
$2.57M Buy
+30,707
New +$2.59M 0.05% 190
2015
Q2
Sell
-23,522
Closed -$1.71M 431
2015
Q1
$1.71M Sell
23,522
-2,202
-9% -$157K 0.03% 216
2014
Q4
$1.77M Buy
25,724
+900
+4% +$60.7K 0.04% 217
2014
Q3
$1.61M Sell
24,824
-7,936
-24% -$502K 0.03% 228
2014
Q2
$2.04M Buy
32,760
+4,912
+18% +$293K 0.04% 227
2014
Q1
$1.64M Sell
27,848
-2,470
-8% -$138K 0.04% 225
2013
Q4
$1.55M Sell
30,318
-2,604
-8% -$130K 0.03% 295
2013
Q3
$1.66M Sell
32,922
-2,272
-6% -$119K 0.04% 285
2013
Q2
$1.73M Buy
+35,194
New +$1.91M 0.04% 272

Other funds holding LLY

Fort Washington Investment Advisors's LLY Position: Q2 2026 in Review

Fort Washington Investment Advisors increased its Eli Lilly (LLY) stake by 0.07% in Q2 2026, buying an estimated $39.8K and bringing the position to 52,264 shares worth $62.7M. The position accounts for 0.32% of the portfolio, ranked #79.

Fort Washington Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fort Washington Investment Advisors held 52,264 shares of Eli Lilly worth $62.7M as of Q2 2026.
  • Fort Washington Investment Advisors bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 0.32% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #79 holding.
  • Fort Washington Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.